
Cogeno Life Science Private Limited
Founded in 2020 and headquartered in Delhi, India.
Founded in 2020 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U33302DL2020PTC374572
374572
Private Limited Indian Non-Government Company
16 Dec 2020
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arunesh Arya ![]() | Director | 16-Dec-2020 | Current |
Sahil Taneja ![]() | Director | 16-Dec-2020 | Current |
Neeru Mehra ![]() | Director | 16-Dec-2020 | Current |
Enhance accessibility to Cogeno Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Cogeno Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Neeru Mehra is a mutual person
Arunesh Arya is a mutual person
Sahil Taneja is a mutual person
Neeru Mehra is a mutual person
Neeru Mehra is a mutual person
There are no open charges registered against the company as per our records.
Cogeno Life Science has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cogeno Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cogeno Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Arunesh Arya was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 4 years 3 months .
Sahil Taneja was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 4 years 3 months .
Neeru Mehra was appointed as a Director was appointed as a Director on 16 Dec 2020 & has been associated with this company since 4 years 3 months .
Cogeno Life Science Private Limited was registered on 16 Dec 2020 with Roc Delhi & aged 4 years 3 months as per MCA records.
Cogeno Life Science Private Limited was incorporated on 16 Dec 2020.
The authorized share capital of Cogeno Life Science Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 3 directors are associated with Cogeno Life Science Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Cogeno Life Science Private Limited is Unit No. 705 Aggarwal Corporate Tower Plot No 23, Dis. Centre Rajendra Place India, Delhi, 110008.
The corporate identification number (CIN) of Cogeno Life Science Private Limited is U33302DL2020PTC374572 and the company number is 374572 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.